Abstract:
Stroke is a leading cause of deaths and long-term disability among the older adults
worldwide. For each successive 10 years after age 55, the stroke rate more than
doubles in both men and women. The walking pattern of a person reflects his neurological
health status of the body. Patients with neurological diseases, such as
stroke, show deviations in walking parameters from normal values. These walking
parameters include step length, stride length, number of steps per minute, stance
and swing duration, double support time and walking velocity. The availability of
an early stroke identification tool can help reduce disability and mortality among
older adults through timely clinical intervention and preventive care. Therefore, a
wearable inertial measurement unit (IMU) sensor-based gait analysis system was
developed to detect stroke-related gait abnormalities and support rehabilitation
monitoring in older adults. The IMU sensor-integrated sock band was developed
using elastic material and attached to the shank (the part of the leg below the knee
and above the ankle) to measure angular velocity and acceleration in the sagittal
plane during walking. These measurements were combined using a gravity-based
complementary filter to detect heel strike and toe-off, which were then used to
calculate gait parameters. A linear regression machine learning model was developed
using Python and Scikit-learn to classify people as healthy or stroke patients
based on gait parameters. This model used a publicly available dataset and aims
to support automatic gait analysis and stroke risk identification. The system supports
single-session gait screening and longitudinal monitoring, comparing sessions
to baselines for classifying status and tracking stroke recovery. The system could
assist doctors in monitoring rehabilitation outcomes and making informed healthcare
decisions. The system has the potential to support clinical decision-making
by assisting physicians in identifying patients with abnormal gait patterns who
may require further clinical assessment.